Want to join the conversation?
$FOSL 2Q15 Q&A: When Saad of Evercore ISI asked the reason for the lower revenue guidance for 2H15, Kosta said that 2015 is a challenging year with significant headwinds and tailwinds and there is a little more uncertainty in the business in the back half of the year than expected.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?